Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T6A Biomarker for Detection of Bacterial Infection in Newborn Infants

NCT07670624 is registered in ClinicalTrials.gov with Salzburger Landeskliniken as lead sponsor.

NCT NCT07670624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07670624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T6A Biomarker for Detection of Bacterial Infection in Newborn Infants
Lead sponsor
Salzburger Landeskliniken
Phase
Observational
Overall status
Recruiting
Start date
September 3, 2026
Completion date
January 31, 2029
Enrollment
210 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker discovery, newborn sepsis, sepsis